These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 33046835)
1. The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database. Okano M; Nomizu T; Tachibana K; Nagatsuka M; Matsuzaki M; Katagata N; Ohtake T; Yokoyama S; Arai M; Nakamura S J Hum Genet; 2021 Mar; 66(3):307-314. PubMed ID: 33046835 [TBL] [Abstract][Full Text] [Related]
2. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2). Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613 [TBL] [Abstract][Full Text] [Related]
3. Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population. Wong ES; Shekar S; Chan CH; Hong LZ; Poon SY; Silla T; Lin C; Kumar V; Davila S; Voorhoeve M; Thike AA; Ho GH; Yap YS; Tan PH; Tan MH; Ang P; Lee AS PLoS One; 2015; 10(7):e0134408. PubMed ID: 26221963 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations]. Duan RR; Sun LX; Zhao HW Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292 [No Abstract] [Full Text] [Related]
6. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer. Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406 [TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population? Alemar B; Gregório C; Herzog J; Matzenbacher Bittar C; Brinckmann Oliveira Netto C; Artigalas O; Schwartz IVD; Coffa J; Alves Camey S; Weitzel J; Ashton-Prolla P PLoS One; 2017; 12(11):e0187630. PubMed ID: 29161300 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564 [TBL] [Abstract][Full Text] [Related]
9. The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population. Idogawa M; Mariya T; Tanaka Y; Saito T; Nakase H; Tokino T; Sakurai A J Hum Genet; 2024 May; 69(5):225-230. PubMed ID: 38409497 [TBL] [Abstract][Full Text] [Related]
10. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome. Mitamura T; Sekine M; Arai M; Shibata Y; Kato M; Yokoyama S; Yamashita H; Watari H; Yabe I; Nomura H; Enomoto T; Nakamura S; Jpn J Clin Oncol; 2020 Dec; 50(12):1380-1385. PubMed ID: 32676635 [TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan. Arai M; Yokoyama S; Watanabe C; Yoshida R; Kita M; Okawa M; Sakurai A; Sekine M; Yotsumoto J; Nomura H; Akama Y; Inuzuka M; Nomizu T; Enomoto T; Nakamura S J Hum Genet; 2018 Apr; 63(4):447-457. PubMed ID: 29176636 [TBL] [Abstract][Full Text] [Related]
13. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642 [TBL] [Abstract][Full Text] [Related]
14. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266 [TBL] [Abstract][Full Text] [Related]
15. Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India. Rajagopal T; Seshachalam A; Jothi A; Rathnam KK; Talluri S; Venkatabalasubranian S; Dunna NR Mol Biol Rep; 2022 Apr; 49(4):3025-3032. PubMed ID: 35020120 [TBL] [Abstract][Full Text] [Related]
16. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center. Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613 [TBL] [Abstract][Full Text] [Related]
17. Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas. Ji G; Bao L; Yao Q; Zhang J; Zhu X; Bai Q; Shao Z; Yang W; Zhou X J Cancer Res Clin Oncol; 2021 Oct; 147(10):2935-2944. PubMed ID: 34254208 [TBL] [Abstract][Full Text] [Related]